Background
Dr. Hayward is a molecular virologist and computational biologist working within the Retroviral Biology and Antivirals research laboratory (RBA). His research involves the identification and characterisation of novel retroviruses in Australian mammals such as bats. He is also involved in research focussed on the microbiome within the female reproductive tract and the metabolites that they produce, with respect to their impact on sexually transmitted infections.
Dr. Hayward is a lecturer in molecular virology at Monash University and post-graduate supervisor of PhD and Honours students within the RBA.
Qualifications
- 2016: PhD in Molecular Microbiology, Monash University, Australia
- 2010: BScAdv(Hons), Monash University, Australia
Awards
- 2020: Jim and Margaret Beever Fellowship
- 2019: Australasian Virology Society Award
- 2018: Harold Mitchell Foundation Postdoctoral Fellowship
- 2018: Ian Potter Award
- 2017: Australasian Virology Society Award
- 2016: Harold Mitchell Foundation Postgraduate Fellowship
- 2015: Monash University Teaching Commendation based on student evaluations
- 2010: Monash University Department of Microbiology Ed Westaway Prize
- 2010: Monash Vice Chancellor’s Honours-PhD Scholarship
Projects (6)
Current (4)
-
Antimicrobial and immune modulatory effects of vaginal microbiota metabolites
-
Burnet Microbiome Initiative
-
Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility
-
Intrinsic host antiviral activity against pathogenic viruses
Publications (10)
2021 (1)
2020 (3)
- Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019.
Helbig KJ, Bull RA, Ambrose R, Beard MR, Blanchard H, Böcking T, Chua B, Colmant AMG, Crosse KM, Purcell DFJ, Fraser J, Hayward JA, Hamilton ST, Husain M, MacDiarmid R, Mackenzie JM, Moseley GW, Nguyen THO, Quiñones-Mateu ME, Robinson K, Rodrigo C, Rodriguez-Andres J, Rudd PA, Werno A, White P, Young P, Speck P, Hibma M, Drummer HE, Tachedjian G
Viruses. 2020 Jun; 12(6):E621
- Infectious KoRV-related retroviruses circulating in Australian bats.
Hayward JA, Tachedjian M, Kohl C, Johnson A, Dearnley M, Jesaveluk B, Langer C, Solymosi PD, Hille G, Nitsche A, Sánchez CA, Werner A, Kontos D, Crameri G, Marsh GA, Baker ML, Poumbourios P, Drummer HE, Holmes EC, Wang LF, Smith I, Tachedjian G
Proc Natl Acad Sci U S A. 2020 Apr; 117(7):9529–9536
- Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ, Tyssen D, Hayward JA, Gugasyan R, Hearps AC, Tachedjian G
Front Cell Infect Microbiol. 2020 Jan; 9:446
2019 (1)
2018 (2)
- Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
Tyssen D, Wang YY, Hayward JA, Agius PA, DeLong K, Aldunate M, Ravel J, Moench TR, Cone RA, Tachedjian G
mSphere. 2018 Jul; 3(4):e00055-18
- Differential evolution of antiretroviral restriction factors in pteropid bats as revealed by APOBEC3 gene complexity.
Hayward JA, Tachedjian M, Cui J, Cheng AZ, Johnson A, Baker M, Harris RS, Wang LF, Tachedjian G
Mol Biol Evol. 2018 Mar; 35(7):1626–1637
2016 (1)
2015 (1)
2013 (1)
News Articles (9)
2020 (3)
2018 (4)
2015 (1)
2012 (1)
